Literature DB >> 15545001

Taurine inhibition of metal-stimulated catecholamine oxidation.

R Dawson1, D Baker, B Eppler, E Tang, D Shih, H Hern, M Hu.   

Abstract

Taurine is an abundant amino acid found in mammalian tissues and it has been suggested to have cytoprotective functions. The aim of the present study was to determine if taurine had the potential to reduce oxidative stress associated with metal-stimulated catecholamine oxidation. Taurine and structural analogs of taurine were tested for their ability to inhibit metal-stimulated quinone formation from dopamine or L-dopa. Oxidative damage to proteins and lipids were also assessed in vitro and the effects of taurine were determined. Taurine (20 mM) was found to decrease significantly ferric iron (50-500 microM)- and manganese (10 microM)-stimulated L-dopa or dopamine oxidation. Taurine had no effect on zinc-induced dopamine oxidation and slightly potentiated copper- and NaIO(4)-stimulated quinone formation. Ferric iron-stimulated lipid peroxidation was not affected by taurine (1-20 mM). Protein carbonyl formation induced by ferric iron (500 microM) and L-dopa (500 microM) was significantly reduced by 10 mM taurine. The cytotoxicity of L-dopa (250 microM) and ferric chloride (75 microM) to LLC-PK(1) cells was attenuated by 10 mM taurine or hypotaurine. Homotaurine alone stimulated L-dopa oxidation and potentiated the cytotoxic effects of ferric iron. Homotaurine was found to be cytotoxic when combined with L-dopa or L-dopa/iron. In contrast, hypotaurine inhibited quinone formation and protected LLC-PK(1) cells. These studies suggest that taurine may exhibit cytoprotective effects against the oxidation products of catecholamines by acting as a scavenger for free radicals and cytotoxic quinones.

Entities:  

Year:  2000        PMID: 15545001     DOI: 10.1007/bf03033322

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  51 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine.

Authors:  G Lévay; Q Ye; W J Bodell
Journal:  Exp Neurol       Date:  1997-08       Impact factor: 5.330

Review 3.  Quinone chemistry and toxicity.

Authors:  T J Monks; R P Hanzlik; G M Cohen; D Ross; D G Graham
Journal:  Toxicol Appl Pharmacol       Date:  1992-01       Impact factor: 4.219

4.  Effect of taurine on toxicity of copper in rats.

Authors:  D F Hwang; L C Wang; H M Cheng
Journal:  Food Chem Toxicol       Date:  1998-03       Impact factor: 6.023

5.  The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.

Authors:  M B Youdim; D Ben-Shachar; G Eshel; J P Finberg; P Riederer
Journal:  Adv Neurol       Date:  1993

6.  Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Authors:  J P Spencer; P Jenner; S E Daniel; A J Lees; D C Marsden; B Halliwell
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

7.  Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

Authors:  B Pardo; M A Mena; M J Casarejos; C L Paíno; J G De Yébenes
Journal:  Brain Res       Date:  1995-06-05       Impact factor: 3.252

8.  Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins.

Authors:  S P Gieseg; J A Simpson; T S Charlton; M W Duncan; R T Dean
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

9.  Effect of age and monosodium-L-glutamate (MSG) treatment on neurotransmitter content in brain regions from male Fischer-344 rats.

Authors:  D R Wallace; R Dawson
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

10.  Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease.

Authors:  J P Spencer; A Jenner; O I Aruoma; P J Evans; H Kaur; D T Dexter; P Jenner; A J Lees; D C Marsden; B Halliwell
Journal:  FEBS Lett       Date:  1994-10-24       Impact factor: 4.124

View more
  2 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Modulatory effects of melatonin on cadmium-induced changes in biogenic amines in rat hypothalamus.

Authors:  Alejandro Romero; Ana Caride; Natividad Pereiro; Anunciación Lafuente
Journal:  Neurotox Res       Date:  2011-01-11       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.